Canlyniadau Chwilio - Chen, Lin-Yu

  • Dangos 1 - 18 canlyniadau o 18
Mireinio'r Canlyniadau
  1. 1
    Inhibition of eIF2α dephosphorylation accelerates pterostilbene-induced cell death in human hepatocellular carcinoma cells in an ER stress and autophagy-dependent manner

    Inhibition of eIF2α dephosphorylation accelerates pterostilbene-induced cell death in human hepatocellular carcinoma cells in an ER stress and autophagy-dependent manner gan Chen‐Lin Yu, Shun‐Fa Yang, Tung‐Wei Hung, Chia‐Liang Lin, Yi‐Hsien Hsieh, Hui‐Ling Chiou

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    High Autophagy in the Naked Mole Rat may Play a Significant Role in Maintaining Good Health

    High Autophagy in the Naked Mole Rat may Play a Significant Role in Maintaining Good Health gan Shanmin Zhao, Lifang Lin, Guanghan Kan, Chang Xu, Qiu Tang, Chen‐Lin Yu, Wei Sun, Liping Cai, Xu Chen, Shufang Cui

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Structure and genome editing of type I-B CRISPR-Cas

    Structure and genome editing of type I-B CRISPR-Cas gan Meiling Lü, Chen‐Lin Yu, Yuwen Zhang, Wenjun Ju, Zhi Y, Chenyang Hua, Jinze Mao, Chunyi Hu, Zhenhuang Yang, Yibei Xiao

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma

    NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma gan Su, Po-Hsuan, Huang, Rui-Lan, Lai, Hung-Cheng, Chen, Lin-Yu, Weng, Yu-Chun, Wang, Chih-Chien, Wu, Chia-Chun

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer

    BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer gan Darmawi, Chen, Lin-Yu, Su, Po-Hsuan, Liew, Phui-Ly, Wang, Hui-Chen, Weng, Yu-Chun, Huang, Rui-Lan, Lai, Hung-Cheng

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway

    Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway gan Hassan, Ayon A., Artemenko, Margarita, Tang, Maggie K. S., Shi, Zeyu, Chen, Lin-Yu, Lai, Hung-Cheng, Yang, Zhenyu, Shum, Ho-Cheung, Wong, Alice S. T.

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Feasibility of terahertz imaging for discrimination of human hepatocellular carcinoma

    Feasibility of terahertz imaging for discrimination of human hepatocellular carcinoma gan Duan, Feng, Wang, Yu-Ye, Xu, De-Gang, Shi, Jia, Chen, Lin-Yu, Cui, Li, Bai, Yan-Hua, Xu, Yong, Yuan, Jing, Chang, Chao

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis

    Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis gan Chen, Lin-Yu, Huang, Rui-Lan, Su, Po-Hsuan, Chu, Ling-Hui, Weng, Yu-Chun, Wang, Hui-Chen, Lai, Hung-Cheng, Wen, Kuo-Chang

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome

    Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome gan Zi-Teng Zhang, Xiu-Ming Du, Xiu‐Juan Ma, Ying Zong, Ji‐Kuai Chen, Chen‐Lin Yu, Yangang Liu, Yongchun Chen, Li-Jun Zhao, Guocai Lu

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

    Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report gan Lin, Yu-Chien, Wen, Kuo-Chang, Sung, Pi-Lin, Chou, Yu-Ting, Liew, Phui-Ly, Chen, Lin-Yu, Huang, Rui-Lan, Lai, Hung-Cheng, Chang, Lu-Te

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis

    Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis gan Chu, Ling-Hui, Liao, Chi-Chun, Liew, Phui-Ly, Chen, Chien-Wen, Su, Po-Hsuan, Wen, Kuo-Chang, Lai, Hung-Cheng, Huang, Rui-Lan, Chen, Lin-Yu

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Using Hebbian-Type Stimulation to Rescue Arm Function After Stroke: Study Protocol for a Randomized Clinical Trial

    Using Hebbian-Type Stimulation to Rescue Arm Function After Stroke: Study Protocol for a Randomized Clinical Trial gan Xu, Rong, Zhu, Guang-Yue, Zhu, Jun, Wang, Yong, Xing, Xiang-Xin, Chen, Lin-Yu, Li, Jie, Shen, Fu-Qiang, Chen, Jian-Bing, Hua, Xu-Yun, Xu, Dong-Sheng

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients

    Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients gan Liao, Yu-Ping, Chen, Lin-Yu, Huang, Rui-Lan, Su, Po-Hsuan, Chan, Michael W.Y., Chang, Cheng-Chang, Yu, Mu-Hsien, Wang, Peng-Hui, Yen, Ming-Shyen, Nephew, Kenneth P., Lai, Hung-Cheng

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer

    Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer gan Su, Po-Hsuan, Lai, Hung-Cheng, Huang, Rui-Lan, Chen, Lin-Yu, Wang, Yu-Chi, Wu, Tzu-I, Chan, Michael W. Y., Liao, Chi-Chun, Chen, Chien‐Wen, Lin, Wei-Yu, Chang, Cheng-Chang

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

    TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target gan Chen, Lin-Yu, Huang, Rui-Lan, Chan, Michael W.Y., Yan, Pearlly S., Huang, Tien-Shuo, Wu, Ren-Chin, Rahmanto, Yohan Suryo, Su, Po-Hsuan, Weng, Yu-Chun, Chou, Jian-Liang, Chao, Tai-Kuang, Wang, Yu-Chi, Shih, Ie-Ming, Lai, Hung-Cheng

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients

    Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients gan Chou, Jian-Liang, Huang, Rui-Lan, Shay, Jacqueline, Chen, Lin-Yu, Lin, Sheng-Jie, Yan, Pearlly S, Chao, Wei-Ting, Lai, Yi-Hui, Lai, Yen-Ling, Chao, Tai-Kuang, Lee, Cheng-I, Tai, Chien-Kuo, Wu, Shu-Fen, Nephew, Kenneth P, Huang, Tim H-M, Lai, Hung-Cheng, Chan, Michael W Y

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1, in ovarian cancer

    Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1, in ovarian cancer gan Yeh, Kun-Tu, Chen, Tze-Ho, Yang, Hui-Wen, Chou, Jian-Liang, Chen, Lin-Yu, Yeh, Chia-Ming, Chen, Yu-Hsin, Lin, Ru-Inn, Su, Her-Young, Chen, Gary CW, Deatherage, Daniel E, Huang, Yi-Wen, Yan, Pearlly S, Lin, Huey-Jen, Nephew, Kenneth P, Huang, Tim H-M, Lai, Hung-Cheng, Chan, Michael WY

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

    Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer gan Chou, Jian-Liang, Su, Her-Young, Chen, Lin-Yu, Liao, Yu-Ping, Hartman-Frey, Corinna, Lai, Yi-Hui, Yang, Hui-Wen, Deatherage, Daniel E., Kuo, Chieh-Ti, Huang, Yi-Wen, Yan, Pearlly S., Hsiao, Shu-Huei, Tai, Chien-Kuo, Lin, Huey-Jen L., Davuluri, Ramana V., Chao, Tai-Kuang, Nephew, Kenneth P., Huang, Tim H.-M., Lai, Hung-Cheng, Chan, Michael W.Y.

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: